e-learning
resources
Stockholm 2007
Monday 17.09.2007
T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Innate immunity in COPD: too much or too little?
P. Hiemstra (Leiden, The Netherlands)
Source:
Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD?
Session:
T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD?
Session type:
Symposium
Number:
2618
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Hiemstra (Leiden, The Netherlands). Innate immunity in COPD: too much or too little?. Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD?
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Adaptive immune system in COPD: auto-immunity or bystander?
Source: Annual Congress 2012 - ERS COPD Research Award Ceremony (supported by Boehringer Ingelheim) followed by the Hot Topic "It takes two to tango: innate and adaptive immunity in COPD"
Year: 2012
Innate immunity and the development of atopy
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010
Innate immune activation in bronchiectasis
Source: Annual Congress 2004 - Immunology of airway and pulmonary disease
Year: 2004
Blocking innate immunity in humans: wise or foolish?
Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases
Year: 2004
Innate immunity is a key factor for the resolution of inflammation in asthma
Source: Eur Respir Rev 2015; 24: 141-153
Year: 2015
Presentation by an expert: Interactions between innate immunity, inflammation and structural cells in pulmonary disease
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013
Innate and adaptive immune response in lung diseases
Source: International Congress 2019 – PG6 Immunodeficiencies in lung diseases
Year: 2019
Oral presentation: Role of B-lymphocytes in a mouse model of chemical-induced asthma Innate immunity and the development of atopy
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010
Dentritic cells: the key link between innate and acquired immunity in airway disease
Source: Annual Congress 2010 - Scientific Year in Review
Year: 2010
Late Breaking Abstract - Human lung microbiota-driven differential innate immune landscape
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020
Late Breaking Abstract - B cell adaptive immune profile in emphysema-predominant COPD
Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2019
Oral presentation: Targeting of microRNAs can restore innate anti-viral response in asthma
Source: Lung Science Conference 2014 - Lung Inflammation and Immunity
Year: 2014
Innate lymphoid cells in isocyanate-induced asthma: role of microRNA-155
Source: Eur Respir J, 56 (3) 1901289; 10.1183/13993003.01289-2019
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept